Find Scholarly Works

Search in all content

Filters for Scholarly Works

Search concepts
Selected Filters

Publication Year

  • 2019
  • 2018
  • 2017
  • 2016
  • 2013
  • 2012
  • 2011

Author

  • Keith Lindor
Article

A 42-Year-Old Woman With a New Diagnosis of Sclerosing Cholangitis

Gossard, A. A. & Lindor, K. D., Jun 1 2012, In : Clinical Gastroenterology and Hepatology. 10, 6, p. 593-597 5 p.

Research output: Contribution to journalArticle

3 Scopus citations
4 Scopus citations

Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis

Hilscher, M., Enders, F. B., Carey, E. J., Lindor, K. & Tabibian, J. H., Mar 1 2016, In : Annals of Hepatology. 15, 2, p. 246-253 8 p.

Research output: Contribution to journalArticle

25 Scopus citations

Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis

Stanich, P. P., Björnsson, E., Gossard, A. A., Enders, F., Jorgensen, R. & Lindor, K. D., Apr 1 2011, In : Digestive and Liver Disease. 43, 4, p. 309-313 5 p.

Research output: Contribution to journalArticle

103 Scopus citations

A model for integration of formal knowledge and clinical experience: The Advanced Doctoring course at Mayo Medical School

Dyrbye, L. N., Starr, S. R., Thompson, G. B. & Lindor, K. D., Sep 2011, In : Academic Medicine. 86, 9, p. 1130-1136 7 p.

Research output: Contribution to journalArticle

9 Scopus citations

Antibiotics for the treatment of primary sclerosing cholangitis

Elfaki, D. A. H. & Lindor, K. D., May 1 2011, In : American Journal of Therapeutics. 18, 3, p. 261-265 5 p.

Research output: Contribution to journalArticle

17 Scopus citations

Antimitochondrial Antibody–Negative Primary Biliary Cholangitis: Is It Really the Same Disease?

Chascsa, D. M. & Lindor, K., Jan 1 2018, (Accepted/In press) In : Clinics in Liver Disease.

Research output: Contribution to journalArticle

3 Scopus citations

An update on cancer risk and surveillance in primary sclerosing cholangitis

Horsley-Silva, J. L., Rodriguez, E. A., Franco, D. L. & Lindor, K., 2017, (Accepted/In press) In : Liver International.

Research output: Contribution to journalArticle

20 Scopus citations

A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis

Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., Trauner, M., Jones, D. E., Floreani, A., Hohenester, S., Luketic, V., Shiffman, M., Van Erpecum, K. J., Vargas, V., Vincent, C., Hirschfield, G. M. & 12 others, Shah, H., Hansen, B., Lindor, K., Marschall, H. U., Kowdley, K. V., Hooshmand-Rad, R., Marmon, T., Sheeron, S., Pencek, R., MacConell, L., Pruzanski, M. & Shapiro, D., Aug 18 2016, In : New England Journal of Medicine. 375, 7, p. 631-643 13 p.

Research output: Contribution to journalArticle

347 Scopus citations

A Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety: Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis

Silveira, M. G., Gossard, A. A., Stahler, A. C., Jorgensen, R. A., Petz, J. L., Ali, A. H. & Lindor, K., Mar 1 2017, In : American Journal of Therapeutics. 24, 2, p. e167-e176

Research output: Contribution to journalArticle

16 Scopus citations

B cell depletion therapy exacerbates murine primary biliary cirrhosis

Dhirapong, A., Lleo, A., Yang, G. X., Tsuneyama, K., Dunn, R., Kehry, M., Packard, T. A., Cambier, J. C., Liu, F. T., Lindor, K., Coppel, R. L., Ansari, A. A. & Gershwin, M. E., Feb 1 2011, In : Hepatology. 53, 2, p. 527-535 9 p.

Research output: Contribution to journalArticle

56 Scopus citations

Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

Tsuda, M., Moritoki, Y., Lian, Z. X., Zhang, W., Yoshida, K., Wakabayashi, K., Yang, G. X., Nakatani, T., Vierling, J., Lindor, K., Gershwin, M. E. & Bowlus, C. L., Feb 1 2012, In : Hepatology. 55, 2, p. 512-521 10 p.

Research output: Contribution to journalArticle

94 Scopus citations

Bone disease in patients with primary sclerosing cholangitis

Angulo, P., Grandison, G. A., Fong, D. G., Keach, J. C., Lindor, K. D., Bjornsson, E. & Koch, A., Jan 2011, In : Gastroenterology. 140, 1, p. 180-188 9 p.

Research output: Contribution to journalArticle

62 Scopus citations

Cancer risk, screening and surveillance in primary sclerosing cholangitis

Chascsa, D. M. & Lindor, K. D., Sep 1 2019, In : Minerva gastroenterologica e dietologica. 65, 3, p. 214-228 15 p.

Research output: Contribution to journalArticle

2 Scopus citations

Challenges of cholangiocarcinoma detection in patients with primary sclerosing cholangitis

Tabibian, J. H. & Lindor, K., 2012, In : Journal of Analytical Oncology. 1, 1, p. 50-55 6 p.

Research output: Contribution to journalArticle

21 Scopus citations

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Kuo, A., Gomel, R., Safer, R., Lindor, K., Everson, G. T. & Bowlus, C. L., Jun 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1372-1378 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

Chemoprevention of colorectal cancer with ursodeoxycholic acid: Cons

Carey, E. J. & Lindor, K., Sep 1 2012, In : Clinics and Research in Hepatology and Gastroenterology. 36, SUPPL.1, p. S61-S64

Research output: Contribution to journalArticle

12 Scopus citations

Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis

Quinn, K. P., Tabibian, J. H. & Lindor, K., Dec 1 2016, (Accepted/In press) In : Scandinavian Journal of Gastroenterology. p. 1-5 5 p.

Research output: Contribution to journalArticle

11 Scopus citations

Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis

Imam, M. H., Thackeray, E. W. & Lindor, K. D., Feb 1 2013, In : Colorectal Disease. 15, 2, p. 198-203 6 p.

Research output: Contribution to journalArticle

9 Scopus citations

Colon Neoplasms Develop Early in the Course of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Thackeray, E. W., Charatcharoenwitthaya, P., Elfaki, D., Sinakos, E. & Lindor, K. D., Jan 1 2011, In : Clinical Gastroenterology and Hepatology. 9, 1, p. 52-56 5 p.

Research output: Contribution to journalArticle

45 Scopus citations

Combination therapy of all-trans retinoic acid with ursodeoxycholic acid in patients with primary sclerosing cholangitis: A human pilot study

Assis, D. N., Abdelghany, O., Cai, S. Y., Gossard, A. A., Eaton, J. E., Keach, J. C., Deng, Y., Setchell, K. D. R., Ciarleglio, M., Lindor, K. & Boyer, J. L., Jan 1 2017, In : Journal of Clinical Gastroenterology. 51, 2, p. e11-e16

Research output: Contribution to journalArticle

16 Scopus citations

Curcumin in hepatobiliary disease: Pharmacotherapeutic properties and emerging potential clinical applications

Hu, R. W., Carey, E. J., Lindor, K. & Tabibian, J. H., Nov 1 2017, In : Annals of Hepatology. 16, 6, p. 835-841 7 p.

Research output: Contribution to journalArticle

14 Scopus citations

Editorial: Itching to Know: Role of Fibrates in PBC

Levy, C. & Lindor, K., Jan 1 2018, In : The American journal of gastroenterology. 113, 1, p. 56-57 2 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations
8 Scopus citations

Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study

Eaton, J. E., Nelson, K. M., Gossard, A. A., Carey, E. J., Tabibian, J. H., Lindor, K. D. & LaRusso, N. F., May 4 2019, In : Scandinavian Journal of Gastroenterology. 54, 5, p. 633-639 7 p.

Research output: Contribution to journalArticle

5 Scopus citations

Emerging drugs for the treatment of Primary Biliary Cholangitis

Ali, A. H., Tabibian, J. H., Carey, E. J. & Lindor, K., Jan 2 2016, In : Expert Opinion on Emerging Drugs. 21, 1, p. 39-56 18 p.

Research output: Contribution to journalArticle

12 Scopus citations

Evaluating sex and gender competencies in the medical curriculum: A case study

Miller, V. M., Flynn, P. M. & Lindor, K. D., Jun 2012, In : Gender Medicine. 9, 3, p. 180-186.e3

Research output: Contribution to journalArticle

10 Scopus citations

Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems

FOLD Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

10 Scopus citations

Farnesoid X receptor agonists for primary biliary cirrhosis

Lindor, K. D., May 1 2011, In : Current Opinion in Gastroenterology. 27, 3, p. 285-288 4 p.

Research output: Contribution to journalArticle

38 Scopus citations

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

the GLOBAL PBC Study Group, Nov 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 10, p. 1127-1136 10 p.

Research output: Contribution to journalArticle

Open Access
5 Scopus citations

Gender differences in academic productivity and leadership appointments of physicians throughout academic careers

Reed, D. A., Enders, F., Lindor, R., McClees, M. & Lindor, K. D., Jan 2011, In : Academic Medicine. 86, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

129 Scopus citations

Hepatic fibrosis and the renin-angiotensin system

Abbas, G., Silveira, M. G. & Lindor, K. D., Nov 1 2011, In : American Journal of Therapeutics. 18, 6, p. e202-e208

Research output: Contribution to journalArticle

21 Scopus citations

Heterogeneity of Outcomes Following Liver Transplantation for Primary Sclerosing Cholangitis: Age Matters

Martin, P. & Lindor, K., Sep 30 2017, (Accepted/In press) In : Digestive Diseases and Sciences. p. 1-2 2 p.

Research output: Contribution to journalArticle

2 Scopus citations

High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

Imam, M. H., Sinakos, E., Gossard, A. A., Kowdley, K. V., Luketic, V. A. C., Edwyn Harrison, M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., Decook, A. C., Enders, F. & Lindor, K. D., Nov 1 2011, In : Alimentary Pharmacology and Therapeutics. 34, 10, p. 1185-1192 8 p.

Research output: Contribution to journalArticle

60 Scopus citations

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis

Cholankeril, G., Gonzalez, H. C., Satapathy, S. K., Gonzalez, S. A., Hu, M., Khan, M. A., Yoo, E. R., Li, A. A., Kim, D., Nair, S., Wong, R. J., Kwo, P. Y., Harrison, S. A., Younossi, Z. M., Lindor, K. & Ahmed, A., Jun 1 2018, In : Clinical Gastroenterology and Hepatology. 16, 6, p. 965-973.e2

Research output: Contribution to journalArticle

8 Scopus citations

Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment

Fibrotic Liver Disease Consortium Investigators, Aug 1 2018, In : Clinical Gastroenterology and Hepatology. 16, 8, p. 1342-1350.e1

Research output: Contribution to journalArticle

14 Scopus citations

Inflammatory bowel disease in primary sclerosing cholangitis: A robust yet changing relationship

Sinakos, E., Samuel, S., Enders, F., Loftus, E. V., Sandborn, W. J. & Lindor, K. D., Apr 1 2013, In : Inflammatory Bowel Diseases. 19, 5, p. 1004-1009 6 p.

Research output: Contribution to journalArticle

28 Scopus citations

Likelihood of malignancy in gallbladder polyps and outcomes following cholecystectomy in primary sclerosing cholangitis

Eaton, J. E., Thackeray, E. W. & Lindor, K. D., Mar 1 2012, In : American Journal of Gastroenterology. 107, 3, p. 431-439 9 p.

Research output: Contribution to journalArticle

51 Scopus citations

Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis

Juliusson, G., Imam, M., Björnsson, E. S., Talwalkar, J. A. & Lindor, K., Jun 2 2016, In : Scandinavian Journal of Gastroenterology. 51, 6, p. 745-752 8 p.

Research output: Contribution to journalArticle

11 Scopus citations

Long-term Outcomes of Patients With Primary Biliary Cirrhosis and Hepatocellular Carcinoma

Imam, M. H., Silveira, M. G., Sinakos, E., Gossard, A. A., Jorgensen, R., Keach, J., DeCook, A. C. & Lindor, K. D., Feb 1 2012, In : Clinical Gastroenterology and Hepatology. 10, 2, p. 182-185 4 p.

Research output: Contribution to journalArticle

13 Scopus citations

Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices

Dong, T. S., Kalani, A., Aby, E. S., Le, L., Luu, K., Hauer, M., Kamath, R., Lindor, K. & Tabibian, J. H., Aug 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 9, p. 1894-1901.e1

Research output: Contribution to journalArticle

3 Scopus citations

Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: Risk factors and time trends in incidence and outcome

Harms, M. H., Lammers, W. J., Thorburn, D., Corpechot, C., Invernizzi, P., Janssen, H. L. A., Battezzati, P. M., Nevens, F., Lindor, K., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Dalekos, G. N., Bruns, T., Parés, A., Mason, A. L., Verhelst, X., Kowdley, K. V., Goet, J. C., Hirschfield, G. M. & 2 others, Hansen, B. E. & Van Buuren, H. R., Feb 1 2018, In : American Journal of Gastroenterology. 113, 2, p. 254-264 11 p.

Research output: Contribution to journalArticle

23 Scopus citations

Managing PBC: Expanding the Provider Comfort Zone

Chascsa, D. M. & Lindor, K., Jun 9 2018, (Accepted/In press) In : Digestive Diseases and Sciences. p. 1-2 2 p.

Research output: Contribution to journalArticle

Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma

Sinakos, E., Saenger, A. K., Keach, J., Kim, W. R. & Lindor, K. D., May 2011, In : Clinical Gastroenterology and Hepatology. 9, 5, p. 434-439.e1

Research output: Contribution to journalArticle

71 Scopus citations

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history

on behalf of the GLOBAL PBC Study Group, May 1 2018, In : Hepatology. 67, 5, p. 1920-1930 11 p.

Research output: Contribution to journalArticle

12 Scopus citations

New treatment strategies for primary sclerosing cholangitis

Lindor, K. D., Jun 1 2011, In : Digestive Diseases. 29, 1, p. 113-116 4 p.

Research output: Contribution to journalArticle

14 Scopus citations

NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A nebulous matter

Tabibian, J. H. & Lindor, K., Jan 1 2019, (Accepted/In press) In : Journal of Hepatology.

Research output: Contribution to journalArticle

3 Scopus citations

Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis

Harms, M. H., De Veer, R. C., Lammers, W. J., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K. D., Trivedi, P. J., Hirschfield, G. M., Pares, A., Floreani, A., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Nevens, F., Ponsioen, C. Y., Mason, A. L., Kowdley, K. V., Hansen, B. E., Buuren, H. R. V. & 1 others, Van Der Meer, A. J., Jan 1 2019, (Accepted/In press) In : Gut. 319057.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Old and new treatments for primary biliary cholangitis

Chascsa, D., Carey, E. J. & Lindor, K., Apr 1 2017, In : Liver International. 37, 4, p. 490-499 10 p.

Research output: Contribution to journalArticle

20 Scopus citations

Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis

Momah, N., Silveira, M. G., Jorgensen, R., Sinakos, E. & Lindor, K. D., May 1 2012, In : Liver International. 32, 5, p. 790-795 6 p.

Research output: Contribution to journalArticle

37 Scopus citations